Oct. 11–12, 2021 • OnlineView Schedule • Registration Rates • Register Now
The safety of our attendees at our in-person events is of the utmost importance at the Society for Immunotherapy of Cancer (SITC). Given the recent increase in the COVID-19 virus and the desire to keep everyone as safe as possible, the Cytokines in Cancer Immunotherapy Workshop, Oct. 11-12, 2021 will now be held virtually. SITC invites you to attend the virtual workshop, Cytokines in Cancer Immunotherapy. This workshop will provide a deeper understanding of cytokines in immune cell proliferation, differentiation, and function, as they pertain to tumor immunobiology and cancer immunotherapy approaches. The virtual format assures a compelling program that can be held safely and successfully, and allows us to accommodate as many participants as possible.To thank you for your continued interest in this workshop given the postponement in 2020 and now a switch to a virtual format, we are happy to be able to offer a 50 percent discount on the registration rate. Register today at the special new rate!The workshop will consist of scientific sessions and expert-led discussion on pressing topics in the field of cytokines in immunology and cancer immunotherapy. This workshop will encourage further investigation into the use of cytokines as solo therapeutic agents as well as in combination with cancer treatments by bringing together established experts and drawing talented new scientists and clinicians into the area of cytokines and immune cell differentiation and function.
It is anticipated that the efforts of this workshop will foster renewed exchange and research on the promising topic of cytokines and their interactions in cancer development and therapy, lead to further research, and provide a solid scientific foundation for future clinical interventions to modulate anti-tumor immunity with combinations of cytokines and other immunotherapies.
This program is intended for basic, translational and clinical researchers in academia and industry with a vested interest in the topic of cytokine immunology and the impact of cytokines in cancer immunotherapy.
To qualify for an Early Career Scientist Travel Award, the primary/presenting author must meet the criteria as outlined below prior to the submission deadline.
If you have questions about this program, please contact the SITC Education team.
This program is supported, in part, by grants from Alkermes, Amgen Inc., Genentech, a member of the Roche Group, Nektar Therapeutics, Pfizer, Inc., Sanofi Genzyme, Simcha Therapeutics Inc, and Synthekine, Inc. (as of 09/23/2021)
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com